UTEBVI Trademark

Trademark Overview

On Tuesday, June 25, 2024, a trademark application was filed for UTEBVI with the United States Patent and Trademark Office. The USPTO has given the UTEBVI trademark a serial number of 98617376. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, December 17, 2024. This trademark is owned by Glaxo Group Limited. The UTEBVI trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
utebvi

General Information

Serial Number98617376
Word MarkUTEBVI
Filing DateTuesday, June 25, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, December 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 25, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events

Event DateEvent Description
Tuesday, June 25, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 17, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, December 17, 2024ASSIGNED TO EXAMINER
Tuesday, December 17, 2024SUSPENSION LETTER WRITTEN
Tuesday, December 17, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, June 25, 2024NEW APPLICATION ENTERED

Related Keywords

utebvi diseases preparations pharmaceutical infectious treatment respiratory hematological bacterial hepatological genitourinary